Alcoholism in Britain? There’s a Pill for That

pill

Everything’s coming up binge drinkers!

Britain’s National Institute for Health and Care Excellence (NICE) has approved the use of Nalmefene, a drug that curbs alcohol dependence. NICE serves the English and Welsh National Health Services (NHS) which allows both nations to join Scotland in prescribing the drug.

The Scottish Medicines Consortium (SMC) approved Nalmefene last year to combat the country’s considerably higher rate of alcohol-related deaths, but all three nations require counseling along with the pill.

Got your acronyms down?

NICE expects 35,000 people to receive the Chantix of alcohol dependency in the first year, but only 53 people in Scotland were prescribed the drug since it hit the market.

Chalk it up to denial?

Since a recent study showed that most Americans who think they might be alcoholics are just excessive drinkers, the target demographic for Nalmefene, the drug may soon be Food and Drug Administration (FDA–acronym game strong) approved for more than opioid dependence.

Whether or not this use of the drug crosses the pond, it’s an interesting, albeit pricey, way to deal with a growing problem.

Pop Quiz: Still remember those acronyms?

H/T: The Guardian

 

More content

CultureLifestyle
Costco Is Raising Employee Wages To $30/Hr
Costco is giving its nonunionized employees a pay raise. In a recent internal memo, CEO Ron Vachris announced that hourly wages for store clerks and…
,
LifestyleProducts
KIND Snacks Is Rallying Behind The New ‘Bed Rot’ Self Care Trend
Self-care comes in many forms–including ‘bed rotting’. And KIND Snacks wants you to embrace yourself… and the rot. KIND has partnered with Ciara Miller and…
,
Eating OutLifestyle
Your Favorite Restaurant Soy Sauce Bottles May Harbor Deadly Bacteria, Warns Nutritionist
Siin Lin Guan Liang, a Malaysian nutritionist, has shared some disturbing findings about restaurant soy sauce bottles. Last month in a Facebook post, he warned…
,
Burger
We Deliver!

Enter your email address below and we'll deliver our top stories straight to your inbox